Monte Rosa Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLUE and other ETFs, options, and stocks.

About GLUE

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA. 

CEO
Markus Warmuth
CEOMarkus Warmuth
Employees
134
Employees134
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2019
Founded2019
Employees
134
Employees134

GLUE Key Statistics

Market cap
1.35B
Market cap1.35B
Price-Earnings ratio
58.12
Price-Earnings ratio58.12
Dividend yield
Dividend yield
Average volume
1.01M
Average volume1.01M
High today
$18.50
High today$18.50
Low today
$17.45
Low today$17.45
Open price
$18.09
Open price$18.09
Volume
1.97M
Volume1.97M
52 Week high
$25.77
52 Week high$25.77
52 Week low
$3.50
52 Week low$3.50

Stock Snapshot

As of today, Monte Rosa Therapeutics(GLUE) shares are valued at $17.90. The company's market cap stands at 1.35B, with a P/E ratio of 58.12.

During the trading session on 2026-03-01, Monte Rosa Therapeutics(GLUE) shares reached a daily high of $18.50 and a low of $17.45. At a current price of $17.90, the stock is +2.6% higher than the low and still -3.2% under the high.

Trading volume for Monte Rosa Therapeutics(GLUE) stock has reached 1.97M, versus its average volume of 1.01M.

The stock's 52-week range extends from a low of $3.50 to a high of $25.77.

The stock's 52-week range extends from a low of $3.50 to a high of $25.77.

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own GLUE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.